NCT03979716

Brief Summary

Nasal polyposis (NP) is a disease affecting 4% of the population. This disease is frequently accompanied by olfactory disorders (41%-84% of patients) that affect patients' quality of life. The aim of this study is to show brain activity differences in olfactory areas before and after surgery in each patient and between patient groups (normosmic, hyposmic and anosmic one) using functional Magnetic Resonance Imaging (fMRI). Brain activity will be measured by the intensity of brain signals and of the size of olfactory areas during olfactory stimulation before and after surgery. We suppose that fMRI could predict whether or not the patient will be able to recover smell after surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 23, 2019

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 7, 2019

Completed
7 months until next milestone

Study Start

First participant enrolled

December 23, 2019

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 23, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 23, 2021

Completed
Last Updated

November 19, 2020

Status Verified

November 1, 2020

Enrollment Period

1.5 years

First QC Date

May 23, 2019

Last Update Submit

November 17, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Functional Brain activity

    Blood Oxygen Level Dependent (BOLD) measures in olfactory areas during calibrated olfactory stimuli in patients with NP whose olfactory function is clinically normal (normosmia), decreased (hyposmia) or absent (anosmia).

    6 months after the last inclusion

Secondary Outcomes (1)

  • Functional Brain activity

    6 months after the last inclusion

Study Arms (3)

Anosmic patients

EXPERIMENTAL
Device: fMRI

Hyposmic patients

EXPERIMENTAL
Device: fMRI

Normosmic patients

EXPERIMENTAL
Device: fMRI

Interventions

fMRIDEVICE

fMRI examination

Anosmic patientsHyposmic patientsNormosmic patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with nasal polyposis managed in the department of otorhinolaryngology and head and neck surgery of Nancy University Hospital,
  • Adult Patients,
  • Justifying a surgical treatment for nasal polyposis,
  • Present hyposmia, anosmia or normosmia before surgery (confirmed by threshold and identification tests of the Sniffin' Stick kit),
  • Affiliated with or beneficiary of a social security scheme,
  • Having received complete information about the study and having signed an informed consent form.

You may not qualify if:

  • General contraindications to Magnetic Resonance Imaging,
  • Female of childbearing age without effective contraception,
  • Persons referred in Articles L. 1121-5 to L. 1121-8 and L1122-2 of the Public Health Code,
  • Qualitative sense of smell disorder (cacosmia, hyperosmia, phantosmia, parosmia),
  • Smell disorders with neurological, post-traumatic, or neurodegenerative origin.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHRU de Nancy

Nancy, 54000, France

RECRUITING

MeSH Terms

Conditions

Nasal Polyps

Interventions

Magnetic Resonance Imaging

Condition Hierarchy (Ancestors)

Nose DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Duc Trung NGUYEN, MD, PhD, MPH

    University Hospital, Nancy, France

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Duc Trung NGUYEN, MD, PhD, MPH

CONTACT

Gabriela HOSSU, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

May 23, 2019

First Posted

June 7, 2019

Study Start

December 23, 2019

Primary Completion

June 23, 2021

Study Completion

June 23, 2021

Last Updated

November 19, 2020

Record last verified: 2020-11

Locations